Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 39Gynecologic 5Sarcoma 3Genitourinary 3Gastrointestinal 2Breast 2Tumor-Agnostic 1Other hematologic neoplasm 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Pathologic Processes 1Neoplastic Processes 1Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Bleomycin × Gastrointestinal × Clear all
NCT04139070 2020-08-20

Electrochemotherapy for Non-curable Gastric Cancer

Zealand University Hospital

Phase 1 Unknown
8 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03040180 2019-01-25

nECT

Zealand University Hospital

Phase 2 Unknown
40 enrolled
Gastrointestinal

Neoplasms, Neoplastic Processes, Pathologic Processes, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡